Humanis Saglik Anonim Sirketi
Clinical trials sponsored by Humanis Saglik Anonim Sirketi, explained in plain language.
-
Generic diabetes pill put to the test against Brand-Name trijardy
Disease control CompletedThis study checked if a new generic pill containing three diabetes medicines (empagliflozin, linagliptin, and metformin) works the same as the brand-name pill Trijardy XR. Fourteen healthy adults took a single dose of each pill in random order. Researchers measured drug levels in…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
Generic diabetes pill put to the test against Brand-Name drug
Knowledge-focused CompletedThis study checked if a generic version of a diabetes pill (Ertugliflozin/Metformin) works the same as the brand-name drug (Segluromet). 36 healthy adults took a single dose of each pill in random order, and researchers measured drug levels in their blood. The goal was to prove t…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 26, 2026 06:31 UTC
-
Generic blood thinner tested against Brand-Name in healthy volunteers
Knowledge-focused CompletedThis study tested whether a generic version of the blood thinner apixaban works the same as the brand-name version. Thirty healthy adults took a single dose of each pill under fasting conditions. The goal was to check if the two drugs are bioequivalent, meaning they are absorbed …
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 26, 2026 06:24 UTC
-
Generic schizophrenia drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a generic 4 mg brexpiprazole tablet works the same as the brand-name drug (Rxulti) in 36 healthy adults aged 45 to 65. Participants took one dose of each drug under fasting conditions, and researchers measured drug levels in the blood to compare them. The go…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 26, 2026 06:22 UTC
-
Generic diabetes combo drug put to the test against Brand-Name synjardy
Knowledge-focused CompletedThis study checked whether a new generic version of a combination diabetes pill (empagliflozin and metformin) releases the same amount of medicine into the body as the brand-name Synjardy XR. Forty healthy adults took a single dose of each pill under fed conditions, and researche…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC
-
Generic cholesterol drug shows promise in small bioequivalence trial
Knowledge-focused CompletedThis study compared a generic bempedoic acid tablet to the brand-name drug Nilemdo in 32 healthy adults. Participants took a single dose under fasting conditions to see if the generic version reaches similar levels in the blood. The goal was to confirm the generic works the same …
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 20, 2026 11:58 UTC
-
Generic acid drug matches brand in healthy volunteer study
Knowledge-focused CompletedThis study checked whether a new generic version of vonoprazan (20 mg) works the same as the brand-name drug Voquezna in healthy adults. Twenty-eight participants took each tablet once under fasting conditions, and blood tests showed the generic was just as effective. The results…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
Generic diabetes drug put to the test against Brand-Name synjardy XR
Knowledge-focused CompletedThis study checked if a generic version of the diabetes drug Synjardy XR (empagliflozin/metformin) is absorbed into the body the same way as the brand-name drug. It involved 32 healthy adults who took a single dose of each version under fasting conditions. The goal was to see if …
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC